Pan-cancer Analyses of Jab1/COPS5 Reveal Oncogenic Role and Clinical Outcome in Human Cancer

Overview

Journal Heliyon

Specialty Social Sciences

Date 2023 Jan 16

PMID 36643321

Authors

Liping Wang

Xiaojiao Zeng

Gui Yang

Guohong Liu

Yunbao Pan

Affiliations

Soon will be listed here.

Abstract

Jab1/COPS5 is associated with the progression of some cancers, however, its role in most cancers is still unclear.This study systematically explored the action and clinical application value of Jab1/COPS5 in different tumors based on large clinical data. We first identified by differential and survival analysis that Jab1/COPS5 was highly expressed as a high-risk gene in most cancers and was closely related to prognostic survival of patients based on the TCGA, GEO and CPTAC databases. Mutation analysis suggested that missense mutations were the main mutation type of Jab1. TMB and MSI were positively correlated with Jab1/COPS5 in most tumors, and patients with Jab1/COPS5 mutations had a poorer prognosis in prostate adenocarcinoma. By immune infiltration analysis, Jab1/COPS5 expression was positively correlated with the infiltration of CD8+ T cells in thymoma and uveal melanoma, and Jab1/COPS5 expression in testicular germ cell tumors was negatively correlated with the infiltration of cancer-associated fibroblasts. Correlation and enrichment analysis suggested that ARMC1, TCEB1 and UBE2V2 were positively correlated with Jab1/COPS5 expression and involved in multiple biological effects. In summary, this study systematically investigated the role of Jab1/COPS5 in different tumors, providing a theoretical basis for Jab1/COPS5 as a new biomarker in unresearched cancers and paving the way for targeted therapy and drug development.

Citing Articles

5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in Lung Cancer.

Shao J, Xu Y, Olsen R, Kasparian S, Sun K, Mathur S Cells. 2024; 13(8.

PMID: 38667328 PMC: 11049556. DOI: 10.3390/cells13080715.

References

Ward Z, Scott A, Hricak H, Abdel-Wahab M, Paez D, Mikhail Lette M . Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis. Lancet Oncol. 2020; 21(8):1077-1088. PMC: 8020599. DOI: 10.1016/S1470-2045(20)30317-X. View

Li P, Gao L, Cui T, Zhang W, Zhao Z, Chen L . Cops5 safeguards genomic stability of embryonic stem cells through regulating cellular metabolism and DNA repair. Proc Natl Acad Sci U S A. 2020; 117(5):2519-2525. PMC: 7007556. DOI: 10.1073/pnas.1915079117. View

Shackleford T, Claret F . JAB1/CSN5: a new player in cell cycle control and cancer. Cell Div. 2010; 5:26. PMC: 2976740. DOI: 10.1186/1747-1028-5-26. View

Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y . Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin Cancer Res. 2001; 7(12):4130-5. View

Kouvaraki M, Rassidakis G, Tian L, Kumar R, Kittas C, Claret F . Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Cancer Res. 2003; 63(11):2977-81. View

Tang Z, Kang B, Li C, Chen T, Zhang Z . GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019; 47(W1):W556-W560. PMC: 6602440. DOI: 10.1093/nar/gkz430. View

Horn S, Stoltzfus K, Lehrer E, Dawson L, Tchelebi L, Gusani N . Epidemiology of liver metastases. Cancer Epidemiol. 2020; 67:101760. DOI: 10.1016/j.canep.2020.101760. View

Sinha S, Dwivedi T, Yengkhom R, Bheemsetty V, Abe T, Kiyonari H . Asrij/OCIAD1 suppresses CSN5-mediated p53 degradation and maintains mouse hematopoietic stem cell quiescence. Blood. 2019; 133(22):2385-2400. DOI: 10.1182/blood.2019000530. View

Danielpour D, Purighalla S, Wang E, Zmina P, Sarkar A, Zhou G . JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer. Biochem Biophys Res Commun. 2019; 518(2):374-380. DOI: 10.1016/j.bbrc.2019.08.066. View

10.

Gupta S, Harper A, Ruan Y, Barr R, Frazier A, Ferlay J . International Trends in the Incidence of Cancer Among Adolescents and Young Adults. J Natl Cancer Inst. 2020; 112(11):1105-1117. PMC: 7669231. DOI: 10.1093/jnci/djaa007. View

11.

Wan Z, Huang S, Mo F, Yao Y, Liu G, Han Z . CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis. Exp Cell Res. 2019; 384(2):111646. DOI: 10.1016/j.yexcr.2019.111646. View

12.

Johnston W, Erdmann F, Newton R, Steliarova-Foucher E, Schuz J, Roman E . Childhood cancer: Estimating regional and global incidence. Cancer Epidemiol. 2020; 71(Pt B):101662. DOI: 10.1016/j.canep.2019.101662. View

13.

Nishimoto A, Takemoto Y, Saito T, Kurazumi H, Tanaka T, Harada E . Nuclear β-catenin expression is positively regulated by JAB1 in human colorectal cancer cells. Biochem Biophys Res Commun. 2020; 533(3):548-552. DOI: 10.1016/j.bbrc.2020.09.007. View

14.

Li J, Li Y, Wang B, Ma Y, Chen P . CSN5/Jab1 facilitates non-small cell lung cancer cell growth through stabilizing survivin. Biochem Biophys Res Commun. 2018; 500(2):132-138. DOI: 10.1016/j.bbrc.2018.03.183. View

15.

Chandrashekar D, Bashel B, Balasubramanya S, Creighton C, Ponce-Rodriguez I, Chakravarthi B . UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017; 19(8):649-658. PMC: 5516091. DOI: 10.1016/j.neo.2017.05.002. View

16.

Clough E, Barrett T . The Gene Expression Omnibus Database. Methods Mol Biol. 2016; 1418:93-110. PMC: 4944384. DOI: 10.1007/978-1-4939-3578-9_5. View

17.

Lee M, Zhao R, Phan L, Yeung S . Roles of COP9 signalosome in cancer. Cell Cycle. 2011; 10(18):3057-66. PMC: 3218617. DOI: 10.4161/cc.10.18.17320. View

18.

Wang Y, Yu Y, Song S, Li T, Xiang J, Zhang H . JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis. J Cancer Res Clin Oncol. 2014; 140(6):969-78. DOI: 10.1007/s00432-014-1646-y. View

19.

Liu G, Yu M, Wu B, Guo S, Huang X, Zhou F . Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51. Cell Signal. 2018; 53:39-48. DOI: 10.1016/j.cellsig.2018.09.010. View

20.

Huang M, Xiong H, Luo D, Xu B, Liu H . CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein. Exp Cell Res. 2020; 388(2):111876. DOI: 10.1016/j.yexcr.2020.111876. View